1. Home
  2. SMID vs MXCT Comparison

SMID vs MXCT Comparison

Compare SMID & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$30.94

Market Cap

157.6M

Sector

Industrials

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.02

Market Cap

136.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
MXCT
Founded
1960
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.6M
136.0M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SMID
MXCT
Price
$30.94
$1.02
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
11.6K
974.5K
Earning Date
04-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
0.25
N/A
Revenue
$93,446,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
$121.12
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$0.64
52 Week High
$43.62
$2.28

Technical Indicators

Market Signals
Indicator
SMID
MXCT
Relative Strength Index (RSI) 56.37 34.79
Support Level $28.01 $0.97
Resistance Level $31.21 $1.16
Average True Range (ATR) 1.11 0.09
MACD 0.19 -0.04
Stochastic Oscillator 69.13 3.26

Price Performance

Historical Comparison
SMID
MXCT

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: